HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hydroxyindole-O-methyltransferase in Y-79 cells: regulation by serum.

Abstract
Hydroxyindole-O-methyltransferase (HIOMT) catalyzes the last step in the synthesis of melatonin. In the present study, the regulation of HIOMT expression was examined in the human Y-79 retinoblastoma cell line. Cells were grown in suspension culture using medium supplemented with 10% fetal calf serum (FCS). HIOMT activity and mRNA were strongly reduced when FCS was substituted with 0.1% bovine serum albumin (BSA), and were restored by addition of FCS. The effect of FCS on HIOMT expression was relatively selective, because the abundance of mRNA encoding actin, G3PDH or interphotoreceptor retinoid-binding protein did not change following serum deprivation. However, S-antigen (arrestin) mRNA was regulated by serum coordinately with HIOMT mRNA, suggesting that S-antigen expression is also controlled by a serum factor. The effect of serum on HIOMT expression was not duplicated by treatment with a series of known differentiating factors, nor was it reduced by dialysis or stripping procedures which remove steroids, growth factors and thyroid hormones.
AuthorsM Bernard, P Voisin, D C Klein
JournalBrain research (Brain Res) Vol. 727 Issue 1-2 Pg. 118-24 (Jul 15 1996) ISSN: 0006-8993 [Print] Netherlands
PMID8842389 (Publication Type: Journal Article)
Chemical References
  • Culture Media
  • Culture Media, Serum-Free
  • DNA Primers
  • RNA, Messenger
  • Acetylserotonin O-Methyltransferase
Topics
  • Acetylserotonin O-Methyltransferase (biosynthesis, isolation & purification, metabolism)
  • Animals
  • Base Sequence
  • Blood
  • Cattle
  • Cell Line
  • Culture Media
  • Culture Media, Serum-Free
  • DNA Primers
  • Eye Neoplasms
  • Humans
  • Kinetics
  • Molecular Sequence Data
  • Polymerase Chain Reaction
  • RNA, Messenger (biosynthesis)
  • Retinoblastoma
  • Transcription, Genetic
  • Tumor Cells, Cultured

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: